MedTrace Logo

Development of Virtual Reality for Nursing Students: Electroconvulsive Therapy

NCT06980831 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-05-20

No results posted yet for this study

Summary

Project: "Development of virtual reality for nursing students: ECT"

For this project the researchers will adapte 'health belief model' as a core concept for developing knowledge, attitude and skills of nursing students to take care of psychiatric patients with ECT. For their practice, the participants will be taught to take care of patients with ECT into 3 phases: before, during, and after ECT.

The researchers believe that this VR technology will help Thai-nursing students better understand and know how to take care of patients with ECT.

This project will consist of two phase. phase I: developing VR- ECT technology for nursing students. we will pilot test VR-ECT in Nursing students by randomizing nursing students volunteers into two groups: an experimental group and waitlist control group (N = 140). Knowledge, attitude and satisfaction and self-confidence will be measured at baseline (day 1), week 8 after intervention complete

Conditions

  • Electroconvulsive Therapy
  • Knowledge, Attitudes, Practice

Interventions

PROCEDURE

ECT group

VR-ECT group, nursing students will practice via virtual reality for taking care of patients with ECT.

Sponsors & Collaborators

  • Mae Fah Luang University

    lead OTHER

Principal Investigators

  • Chuntana Reangsing, PhD, RN · School of Nursing ,Mae Fah Luang University, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-06-30
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06980831 on ClinicalTrials.gov